29 November 2012

Results of 2012 Annual General Meeting Incorporating Proxy Results

Adelaide, Australia, 29 November 2012 – Ellex Medical Lasers Limited (ASX:ELX), a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, confirms in accordance with Listing Rule 3.13.2, the results for each of the resolutions put to the Annual General Meeting held at 2:00 pm on Thursday 29 November 2012 was as follows:

Ordinary Business:

Resolution 2: Re-election of Malcolm Plunkett as a director

The instructions given to validly appointed proxies in respect of the Resolution were as follows:

For Against Open Usable Abstain Excluded
29,550,433 5,572,548 570,966 128,880 0

Result: Resolution Carried by a show of hands

Resolution 3: Adoption of Remuneration Report

The instructions given to validly appointed proxies in respect of the Resolution were as follows:

For Against Open Usable Abstain Excluded
9,606,770 5,764,136 509,366 15,000 19,927,555

This resolution was passed as an ordinary resolution with 67.8% of votes cast in favour and 32.2% against.

Poll Result

For Against Open Usable Abstain Excluded
12,147,774 5,764,256 15,000 19,927,555

Result: With more than 25% of the votes against the Resolution, Ellex was delivered “a Second Strike” under the new legislation, necessitating the Spill Resolution.

Special Business

Resolution 4: Conditional Resolution to hold Director elections at special meeting: “Spill Resolution”.

The instructions given to validly appointed proxies in respect of the Resolution were as follows:

For Against Open Usable Abstain Excluded
6,344,831 8,792,148 609,311 148,982 19,927,555

This resolution was not supported on a poll as an ordinary resolution, as 35.5% of the votes cast on the resolution were “for” the resolution, while 64.5% of the votes were cast “against” the resolution. More than 50% of votes cast were needed to pass the Resolution.

Poll Result

For Against Open Usable Abstain Excluded
6,345,299 11,506,749 148,982 19,927,555

Result: Resolution Lost: There is not a requirement to hold a Special Meeting. All the Directors retain their current positions.

Meeting closed at 3.15pm.

Giuseppe Canala

Company Secretary

ABOUT ELLEX

Ellex Medical Lasers Limited (ASX:ELX) is a global leader in the design and manufacture of ophthalmic laser and ultrasound systems used by ophthalmologists to diagnose and treat eye disease. With more than 16,000 systems delivered to the market, Ellex has evolved since 1985 from a manufacturing company of primarily OEM products, to direct marketing of its own branded products through subsidiaries in the United States, Japan, Germany and Australia, and a network of distribution partners in more than 100 countries. In recent years, Ellex has diversified its product range beyond lasers and ultrasound equipment to include distribution of a number of complementary third-party ophthalmic products.